This announcement is a separate document:
九典制药：湖南启元律师事务所关于公司2022年限制性股票激励计划相关事项调整、首次授予部分第一个归属期条件成就及部分已授予尚未归属的限制性股票作废事项的法律意见书
Jiudian Pharmaceutical: Legal opinion of Hunan Qiyuan Law Firm on the adjustment of matters relating to the company\'s 2022 restricted stock incentive plan, the achievement of some of the first vesting period conditions for the first time, and the annulmen
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.